Literature DB >> 10439492

Indication-based use of antimicrobials in Finnish primary health care. Description of a method for data collection and results of its application.

U M Rautakorpi1, J Lumio, P Huovinen, T Klaukka.   

Abstract

OBJECTIVE: To collect population-based information on treatment of infections with antibiotics in PHC.
DESIGN: A questionnaire study for general practitioners (GPs).
SETTING: All health centres of Pirkanmaa Hospital District in Finland. PATIENTS: Patients with any infection attending health centre during 1 week in November 1994. MAIN OUTCOME MEASURES: An infection diagnosis by the GP.
RESULTS: A total of 4150 questionnaires were received from 223 doctors. Respiratory tract infections comprised 80% of all infections. Of all patients 64% received antimicrobial treatment. Unspecified upper respiratory tract infections and pharyngitis were rarely treated with antimicrobials (10 and 21%, respectively), whereas patients with acute bronchitis received antibiotics as often (83%) as patients with otitis media (93%) or tonsillitis (86%). The most commonly prescribed substances were cephalosporins (19% of all antimicrobials), penicillin V (17%), and amoxycillin (17%). Half of the cephalosporin use could be regarded as overuse. Half of the sulphatrimethoprims were used for otitis media. A quarter of the patients expressed a desire to receive antibiotic treatment.
CONCLUSION: The method was practical, inexpensive, and successful in giving such information, which is needed for supervising the rational use of antibiotics in primary health care.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10439492     DOI: 10.1080/028134399750002719

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  6 in total

1.  Detection of Group A Streptococcus from Pharyngeal Swab Samples by Bacterial Culture Is Challenged by a Novel mariPOC Point-of-Care Test.

Authors:  Jukka Vakkila; Janne O Koskinen; Annika Brandt; Anna Muotiala; Viivi Liukko; Sari Soittu; Siiri Meriluoto; Marika Vesalainen; Pentti Huovinen; Kerttu Irjala
Journal:  J Clin Microbiol       Date:  2015-04-22       Impact factor: 5.948

2.  Trends in number of consultations and antibiotic prescriptions for respiratory tract infections between 1999 and 2005 in primary healthcare in Kalmar County, Southern Sweden.

Authors:  Thomas Neumark; Lars Brudin; Sven Engstrom; Sigvard Molstad
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

3.  Drug utilisation in outpatient children. A comparison among Tenerife, Valencia, and Barcelona (Spain), Toulouse (France), Sofia (Bulgaria), Bratislava (Slovakia) and Smolensk (Russia).

Authors:  E Sanz; M A Hernández; S Ratchina; L Stratchounsky; M A Peiré; M Lapeyre-Mestre; B Horen; M Kriska; H Krajnakova; H Momcheva; D Encheva; I Martínez-Mir; V Palop
Journal:  Eur J Clin Pharmacol       Date:  2004-03-12       Impact factor: 2.953

4.  Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial.

Authors:  Daniel Drozdov; Anja Thomer; Marc Meili; Stefanie Schwarz; Rita Bossart Kouegbe; Katharina Regez; Merih Guglielmetti; Ursula Schild; Antoinette Conca; Petra Schäfer; Barbara Reutlinger; Cornelia Ottiger; Florian Buchkremer; Alexander Litke; Philipp Schuetz; Andreas Huber; Ulrich Bürgi; Christoph A Fux; Andreas Bock; Beat Müller; Werner C Albrich
Journal:  Trials       Date:  2013-03-22       Impact factor: 2.279

5.  Cross-sectional prospective survey to study indication-based usage of antimicrobials in animals: results of use in cattle.

Authors:  Katariina Thomson; Merja Rantala; Maria Hautala; Satu Pyörälä; Liisa Kaartinen
Journal:  BMC Vet Res       Date:  2008-04-14       Impact factor: 2.741

6.  Procalcitonin determined at emergency department as na early indicator of progression to septic shock in patient with sepsis associated with ureteral calculi.

Authors:  Young Hwii Ko; Yoon Seob Ji; Sin-Youl Park; Su Jin Kim; Phil Hyun Song
Journal:  Int Braz J Urol       Date:  2016 Mar-Apr       Impact factor: 1.541

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.